Givinostat Hydrochloride - Cohort 2 clinical trials

Pharmacokinetics and Safety of Givinostat in DMD Patients Ages From at Least 2 Years to Less Then 6 Years Old

This study is looking at a new medicine called Givinostat for boys with Duchenne Muscular Dystrophy (DMD) between 2 and 6 years old. It aims to see how the medicine works in their bodies and if it is safe for them.